Mifamurtide

Generic name
Mifamurtide
Brand name
ATC Code
L03AX15
Compare …

Mifamurtide

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Oncological conditions
  • Intravenous
    • ≥ 2 years

      • The dosage and dosing frequency of oncological agents depend on the condition and are very much subject to new insights. Oncological drugs are often used in combinations. For this reason, please refer to the detailed treatment protocols (see www.skion.nl)

        The following indicative dosages have been stated by the manufacturer:
        Combined with other chemotherapy agents: 2 mg/m² BSA twice a week at intervals of at least 3 days for 12 weeks, followed by 2 mg/m² BSA once a week for 24 weeks.

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

IMMUNOSTIMULANTS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Colony stimulating factors
L03AA02
L03AA14
Interferons
L03AB05
L03AB11
L03AB10
Other immunostimulants
L03AX13
L03AX16

Reference

  1. Takeda France SAS, SmPC MEPACT (EU/1/08/502/001) 22-02-2016, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose